HtrA serine peptidase 1
Last updated 11 Apr 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The HTRA1 gene provides instructions for making a protein that is found in many of the body's organs and tissues. This protein is a type of enzyme called a serine protease, which has an active center that cuts (cleaves) other proteins into smaller pieces. The HTRA1 enzyme helps break down many other kinds of proteins in the space surrounding cells (the extracellular matrix).
Video picks for GenesVideo library
Normal function
The HTRA1 gene provides instructions for making a protein that is found in many of the body's organs and tissues. This protein is a type of enzyme called a serine protease, which has an active center that cuts (cleaves) other proteins into smaller pieces. The HTRA1 enzyme helps break down many other kinds of proteins in the space surrounding cells (the extracellular matrix).
The HTRA1 enzyme also attaches (binds) to proteins in the transforming growth factor-beta (TGF-β) family and slows down (inhibits) their ability to send chemical signals. TGF-β proteins normally help control many critical cell functions, including the growth and division (proliferation) of cells, the process by which cells mature to carry out specific functions (differentiation), cell movement (motility), and the self-destruction of cells (apoptosis). TGF-β signaling also plays an important role in the formation of new blood vessels (angiogenesis).
Researchers have proposed several additional functions for the HTRA1 enzyme. It may play a role in the stabilization of microtubules, which are rigid, hollow fibers that make up the cell's structural framework (cytoskeleton). Additionally, the HTRA1 enzyme may be involved in depositing minerals, such as calcium and phosphorus, in developing bone (mineralization). Studies have also suggested that the HTRA1 enzyme acts as a tumour suppressor, a protein that helps prevent the development of cancerous tumours by keeping cells from growing and dividing in an uncontrolled way.
Conditions referring to this gene or chromosome
Other names
ARMD7
HtrA
HTRA1_HUMAN
IGFBP5-protease
L56
ORF480
protease, serine, 11 (IGF binding)
PRSS11
serine protease HTRA1
Patient picks for Genes

PID Q&A
Does PID cause bleeding?
Dr Sarah Jarvis MBE Symptoms may develop quickly. You can become quite ill over a few days. Sometimes symptoms are mild and develop slowly. For example, you may just have a mild abdominal pain that may 'grumble on' for weeks. In some cases no symptoms develop and you do not know that you are infected. However, you are still at risk of complications even if you have no symptoms at first. [https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-1](https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-1)
by Dr Sarah Jarvis

PID Q&A
How do you diagnose PID?
Dr Sarah Jarvis MBE Symptoms may develop quickly. You can become quite ill over a few days. Sometimes symptoms are mild and develop slowly. For example, you may just have a mild abdominal pain that may 'grumble on' for weeks. In some cases no symptoms develop and you do not know that you are infected. However, you are still at risk of complications even if you have no symptoms at first. [https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-1](https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-1)
by Dr Sarah Jarvis

Meningitis Q&A
Why do teenagers need a meningitis vaccine?
Dr Sarah Jarvis MBE If you are under the age of 25 and have not been immunised, see your doctor or practice nurse to get immunised. This is particularly important if you are about to start university for the first time, as the risk of infection with group W meningococcus is highest in first-year university students. Just one injection of vaccine is needed if you are over the age of 1 year. For more information on the meningitis vaccine, go to [https://patient.info/health/meningitis-leaflet/meningococcal-meningitis-vaccine](https://patient.info/health/meningitis-leaflet/meningococcal-meningitis-vaccine)
by Dr Sarah Jarvis

Risks of diabetes
What can someone with type 1 diabetes do to stop their glucose going too high?
Dr Sarah Jarvis MBE For more information on continuous glucose monitoring, go to [https://patient.info/health/type-1-diabetes/features/continuous-glucose-monitoring-in-type-1-diabetes](https://patient.info/health/type-1-diabetes/features/continuous-glucose-monitoring-in-type-1-diabetes)
by Dr Sarah Jarvis

STI
How do you get genital warts?
Dr Sarah Jarvis MBE The virus is passed on by sexual contact. You need close skin-to-skin contact to pass on the virus. This means that you do not necessarily need to have penetrative sex to pass on infection. Sharing sex toys may also pass on infection. Very rarely, anogenital warts may be passed on from hand warts. They may also rarely be passed on to a baby when a woman gives birth. [https://patient.info/health/sexually-transmitted-infections-leaflet/anogenital-warts#nav-1](https://patient.info/health/sexually-transmitted-infections-leaflet/anogenital-warts#nav-1)
by Dr Sarah Jarvis

Risks of diabetes
How can I avoid getting a hypo?
Dr Sarah Jarvis MBE Hypoglycaemia, or low blood sugar, is often known as a 'hypo'. It can make you feel unwell and affect your ability to drive. Simple steps will reduce the risk, and allow you to treat a hypo early, before it causes more serious complications. For more information, go to [https://patient.info/health/type-1-diabetes/features/how-low-blood-sugar-is-dangerous](https://patient.info/health/type-1-diabetes/features/how-low-blood-sugar-is-dangerous)
by Dr Sarah Jarvis
Related patient information and medicines

Patient information leaflet
Giant Cell Arteritis
As long as the tests are performed within a week of starting the treatment, ... The main aim is to reduce the risk of possible complications. The second aim is to relieve the headache and any other symptoms. Steroid tablets A steroid medicine Oral steroids such as prednisolone Prednisolone is the usual main treatment. Steroids work by reducing.

Patient information leaflet
Kidney stones
Kidney stones are hard stones that can cause severe pain in your side along with blood in your urine, and nausea and vomiting. You are more likely to develop kidney stones if you eat a Western diet, don't drink enough fluids or are overweight. Once you have had one episode they are likely to recur but there are several kidney stone treatment.

Patient information leaflet
Type 2 diabetes treatment
The rest of this leaflet is about medications to control blood glucose. DPP-4 (dipeptidyl peptidase-4) inhibitors - also known as incretin enhancers This group includes alogliptin Alogliptin tablets for diabetes , linagliptin Linagliptin tablets for diabetes , saxagliptin Saxagliptin for diabetes , sitagliptin Sitagliptin for diabetes and.

Patient information leaflet
Telogen effluvium
Telogen effluvium (hair loss) is a condition where more than normal amounts of hair fall out. There is a general 'thinning' of the hair. Many other medications have been linked to telogen effluvium, but some of the most common are beta-blockers; retinoids, including excess vitamin A (often used for skin problems); anticoagulants (often called.

Patient information leaflet
Topical steroids for eczema
A very strong topical steroid. You should use topical steroids until the flare-up has completely gone and then stop using them. In many cases, a course of treatment for 7-14 days is enough to clear a flare-up of eczema. In some cases, a longer course is needed; this should not be done without medical advice. Many people with eczema require a.

Patient information leaflet
Haemophilia
Haemophilia is a rare bleeding disorder that affects your ability to make a clot. The blood contains substances called clotting factors that work with platelets to form a clot. When you injure yourself the clot stops you bleeding. Haemophilia is a condition where there is a deficiency of clotting factors, so people with this condition usually have.
Further reading and references
- HtrA serine peptidase 1; MedlinePlus, National Library of Medicine.
- An E, Sen S, Park SK, Gordish-Dressman H, Hathout Y. Identification of novel substrates for the serine protease HTRA1 in the human RPE secretome. Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3379-86. doi: 10.1167/iovs.09-4853. Epub 2010 Mar 5.
- Chien J, Ota T, Aletti G, Shridhar R, Boccellino M, Quagliuolo L, Baldi A, Shridhar V. Serine protease HtrA1 associates with microtubules and inhibits cell migration. Mol Cell Biol. 2009 Aug;29(15):4177-87. doi: 10.1128/MCB.00035-09. Epub 2009 May 26.
- Dewan A, Liu M, Hartman S, Zhang SS, Liu DT, Zhao C, Tam PO, Chan WM, Lam DS, Snyder M, Barnstable C, Pang CP, Hoh J. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science. 2006 Nov 10;314(5801):989-92. doi: 10.1126/science.1133807. Epub 2006 Oct 19.
- Fukutake T. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): from discovery to gene identification. J Stroke Cerebrovasc Dis. 2011 Mar-Apr;20(2):85-93. doi: 10.1016/j.jstrokecerebrovasdis.2010.11.008. Epub 2011 Jan 7.
- Hara K, Shiga A, Fukutake T, Nozaki H, Miyashita A, Yokoseki A, Kawata H, Koyama A, Arima K, Takahashi T, Ikeda M, Shiota H, Tamura M, Shimoe Y, Hirayama M, Arisato T, Yanagawa S, Tanaka A, Nakano I, Ikeda S, Yoshida Y, Yamamoto T, Ikeuchi T, Kuwano R, Nishizawa M, Tsuji S, Onodera O. Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N Engl J Med. 2009 Apr 23;360(17):1729-39. doi: 10.1056/NEJMoa0801560.
- Kanda A, Chen W, Othman M, Branham KE, Brooks M, Khanna R, He S, Lyons R, Abecasis GR, Swaroop A. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16227-32. doi: 10.1073/pnas.0703933104. Epub 2007 Sep 20.
- Shiga A, Nozaki H, Yokoseki A, Nihonmatsu M, Kawata H, Kato T, Koyama A, Arima K, Ikeda M, Katada S, Toyoshima Y, Takahashi H, Tanaka A, Nakano I, Ikeuchi T, Nishizawa M, Onodera O. Cerebral small-vessel disease protein HTRA1 controls the amount of TGF-beta1 via cleavage of proTGF-beta1. Hum Mol Genet. 2011 May 1;20(9):1800-10. doi: 10.1093/hmg/ddr063. Epub 2011 Feb 14.
- Tong Y, Liao J, Zhang Y, Zhou J, Zhang H, Mao M. LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis. Mol Vis. 2010 Oct 5;16:1958-81.
- Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, Chen H, Zhao Y, Pearson E, Li X, Chien J, Dewan A, Harmon J, Bernstein PS, Shridhar V, Zabriskie NA, Hoh J, Howes K, Zhang K. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science. 2006 Nov 10;314(5801):992-3. doi: 10.1126/science.1133811. Epub 2006 Oct 19.
- Yang Z, Tong Z, Chen Y, Zeng J, Lu F, Sun X, Zhao C, Wang K, Davey L, Chen H, London N, Muramatsu D, Salasar F, Carmona R, Kasuga D, Wang X, Bedell M, Dixie M, Zhao P, Yang R, Gibbs D, Liu X, Li Y, Li C, Li Y, Campochiaro B, Constantine R, Zack DJ, Campochiaro P, Fu Y, Li DY, Katsanis N, Zhang K. Genetic and functional dissection of HTRA1 and LOC387715 in age-related macular degeneration. PLoS Genet. 2010 Feb 5;6(2):e1000836. doi: 10.1371/journal.pgen.1000836.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

